(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE COMBINAÇÃO COM ANTAGONISTAS DE RECEPTOR DE ADENOSINA

ArquivadaInvention PatentPCT · US2021044935

Application data

Number

112023002180

Type

Invention Patent

Filing

08/06/2021

Publication

05/02/2023

PCT

US2021044935

Progress at the INPI

  1. Filing08/06/21
  2. Publication05/02/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/06/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/05/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TEON THERAPEUTICS, INC.

US

Inventors

E. E. (pessoa física)

US

J. L. (pessoa física)

US

L. Y. (pessoa física)

US

P. F. (pessoa física)

US

Technical data

Priority claims

US

63/062,857 · 08/07/2020

Abstract

TERAPIA DE COMBINAÇÃO COM ANTAGONISTAS DE RECEPTOR DE ADENOSINA.Trata-se de compostos, composições, formulações e métodos para modular o receptor de adenosina A2B em combinação com inibidores de ponto de verificação imune em mamíferos com câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

11/05/2024

RPI 2809

Arquivamento - Art. 33 da LPI

#11.1

08/20/2024

RPI 2798

Notificação de entrada na fase nacional - PCT

#1.3

05/02/2023

RPI 2730

Alteração de dados cadastrais

#1.1

02/14/2023

RPI 2719

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.